<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND/PURPOSE: Despite the similar clinical phenotype of the Saethre-Chotzen and Muenke <z:e sem="disease" ids="C0010278" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="CRS|CSO|CRS1">craniosynostoses</z:e>, the 2 syndromes are now genotypically distinct </plain></SENT>
<SENT sid="1" pm="."><plain>Patients with Saethre-Chotzen and Muenke syndromes carry mutations in the TWIST and fibroblast growth factor receptor (FGFR) 3 genes, respectively </plain></SENT>
<SENT sid="2" pm="."><plain>We sought to assess possible ocular phenotypic differences in patients with mutations of either gene previously grouped according to phenotype only </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: A retrospective chart review was performed for 21 children with known mutations of the TWIST (n=10) or the FGFR3 (n=11) genes </plain></SENT>
<SENT sid="4" pm="."><plain>Data gathered included patient sex, age, family craniofacial history, craniofacial and ophthalmic surgeries, type of <z:hpo ids='HP_0000486'>strabismus</z:hpo>, <z:hpo ids='HP_0000508'>ptosis</z:hpo>, cycloplegic refraction, visual acuity, the presence of <z:hpo ids='HP_0000646'>amblyopia</z:hpo>, <z:hpo ids='HP_0000579'>nasolacrimal duct obstruction</z:hpo> (NLDO), <z:hpo ids='HP_0000639'>nystagmus</z:hpo>, <z:hpo ids='HP_0000316'>hypertelorism</z:hpo>, <z:hpo ids='HP_0000286'>epicanthal fold</z:hpo> anomalies, and any ocular structural abnormalities </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: In the TWIST group, <z:hpo ids='HP_0000508'>ptosis</z:hpo> was present in 90%, <z:hpo ids='HP_0000646'>amblyopia</z:hpo> in 70%, horizontal <z:hpo ids='HP_0000486'>strabismus</z:hpo> in 70%, vertical <z:hpo ids='HP_0000486'>strabismus</z:hpo> in 60%, NLDO in 60%, <z:hpo ids='HP_0000483'>astigmatism</z:hpo> in 50%, inferior oblique overaction (IOOA) in 40%, <z:hpo ids='HP_0000540'>hyperopia</z:hpo> in 40%, <z:hpo ids='HP_0000545'>myopia</z:hpo> in 30%, <z:hpo ids='HP_0000639'>nystagmus</z:hpo> in 30%, and optic nerve findings in 30% </plain></SENT>
<SENT sid="6" pm="."><plain>In the FGFR3 group, <z:hpo ids='HP_0000508'>ptosis</z:hpo> was present in 36%, <z:hpo ids='HP_0000646'>amblyopia</z:hpo> in 18%, horizontal <z:hpo ids='HP_0000486'>strabismus</z:hpo> in 55%, vertical <z:hpo ids='HP_0000486'>strabismus</z:hpo> in 36%, NLDO in 0%, <z:hpo ids='HP_0000483'>astigmatism</z:hpo> in 9%, IOOA in 45%, <z:hpo ids='HP_0000540'>hyperopia</z:hpo> in 27%, <z:hpo ids='HP_0000545'>myopia</z:hpo> in 18%, <z:hpo ids='HP_0000639'>nystagmus</z:hpo> in 18%, and optic nerve findings in 27% </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: Patients with TWIST gene mutations may have more ophthalmic abnormalities, including more <z:hpo ids='HP_0000486'>strabismus</z:hpo>, <z:hpo ids='HP_0000508'>ptosis</z:hpo>, NLDO, <z:hpo ids='HP_0000483'>astigmatism</z:hpo>, vertical deviations, and <z:hpo ids='HP_0000646'>amblyopia</z:hpo> compared with patients with FGFR3 gene mutations </plain></SENT>
</text></document>